According to an April 15 survey by healthcare company Tebra, more than a third of users of glucagon-like peptide-1 (GLP-1) receptor agonists are currently microdosing Ozempic and similar prescriptions, primarily due to the potential side effects associated with the drugs
However, when the glucose load exceeds the renal glucose threshold, as is the case in people with uncontrolled hyperglycemia, glucose begins to appear in the urine a clinical finding termed glucosuria
Were committed to continuing to monitor the sector, work with the MHRA and GPhC, and to take action where problem ads appear. MHRA's executive director of healthcare, quality and access, Julian Beach, the MHRA's Executive Director of Healthcare, Quality and Access, said, This research is a valuable contribution to our understanding of how weight-loss treatment advertising is perceived by the public
Animal and translational work hints at synergy between estrogen signaling and GLP-1 pathways, raising the possibility that fluctuating sex hormone states (menstrual cycle, menopause, exogenous hormones) may shape both efficacy and side-effect profiles (Vigil et al., 2022
These drugs are not safe during pregnancy
This means tirzepatide preferentially improves body composition, shifting the ratio in favor of lean mass even as total weight decreases